propranolol has been researched along with Airflow Obstruction, Chronic in 8 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To verify the previously reported association between long-term use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson disease (PD), respectively." | 1.51 | Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. ( Blaabjerg, M; Christensen, K; Deuschl, G; Höglinger, GU; Hopfner, F; Kuhlenbäumer, G; Pottegård, A; Rösler, TW; Wod, M, 2019) |
| "Progression of chronic obstructive pulmonary disease is associated with small airway obstruction by accumulation of inflammatory mucous exudates." | 1.40 | β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling. ( Guo, Y; He, B; Xu, M; Zhang, Y; Zhou, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jude, JA | 1 |
| Dainty, I | 1 |
| Karmacharya, N | 1 |
| Jester, W | 1 |
| Panettieri, R | 1 |
| Hopfner, F | 1 |
| Wod, M | 1 |
| Höglinger, GU | 1 |
| Blaabjerg, M | 1 |
| Rösler, TW | 1 |
| Kuhlenbäumer, G | 1 |
| Christensen, K | 1 |
| Deuschl, G | 1 |
| Pottegård, A | 1 |
| Wang, H | 1 |
| Gomez, DR | 1 |
| Liao, Z | 1 |
| Zhou, Y | 1 |
| Zhang, Y | 2 |
| Guo, Y | 1 |
| Xu, M | 1 |
| He, B | 1 |
| Islami, H | 1 |
| Veseli, A | 1 |
| Behluli, E | 1 |
| Morina, N | 1 |
| Lagente, V | 1 |
| Naline, E | 1 |
| Guenon, I | 1 |
| Corbel, M | 1 |
| Boichot, E | 1 |
| Burgaud, JL | 1 |
| Del Soldato, P | 1 |
| Advenier, C | 1 |
| van der Woude, HJ | 1 |
| Zaagsma, J | 1 |
| Postma, DS | 1 |
| Winter, TH | 1 |
| van Hulst, M | 1 |
| Aalbers, R | 1 |
1 trial available for propranolol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Bronchial Hyperreactivity; Bronc | 2005 |
7 other studies available for propranolol and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β
Topics: Adrenergic Agonists; Bronchodilator Agents; Histamine; Humans; Lung; Muscarinic Antagonists; Propran | 2023 |
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adrenergic beta-Antag | 2019 |
β-Blockers and metastasis in non-small-cell lung cancer.
Topics: Adrenergic beta-Antagonists; Animals; Carcinoma, Non-Small-Cell Lung; gamma-Aminobutyric Acid; Human | 2013 |
β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Arrestins; beta-Arrestins; Cell Line, Tumor; Humans | 2014 |
[Obstructive respiratory tract diseases: contraindications to beta blockers crumble].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Comorbidit | 2014 |
Importance of the adrenergic nerve system in the response of gases in the arterial blood following the provoked bronchospasm.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Adul | 2012 |
A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.
Topics: Albuterol; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage; Bronchodilator Agents; Cell Mo | 2004 |